Oral Controlled Release Drug Delivery Technology Market to Reach Nearly US$ 50,000 Million by 2027


Posted December 15, 2017 by hawerr

Oral Controlled Release Drug Delivery Technology Market: Diffusion Controlled Release System Anticipated to be the Most Attractive Segment During the Forecast Period: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 – 2027

 
Future Market Insights (FMI), in its report, projects the global oral controlled release drug delivery technology market to register an impressive expansion at 7.2% CAGR during the forecast period 2017 to 2027. The market will surpass revenues worth US$ 20,000 Mn in 2017, and is further estimated to reach nearly US$ 50,000 Mn by 2027-end.

Report overview@ https://www.futuremarketinsights.com/reports/oral-controlled-release-drug-delivery-technology-market

By drug release technology, dissolution-controlled release system will remain sought-after in the market, followed by diffusion-controlled release system. Majority of generic formulations available are in tablet dosage form and follow dissolution-controlled release mechanism. Revenues from sales of dissolution-controlled release system will surpass US$ 10,000 Mn in 2017. Demand for hydrodynamically-balanced drug delivery system will remain sluggish in the market.

FMI’s report estimates North America to remain the largest market for oral controlled release drug delivery technology, with sales estimated to reach nearly US$ 20,000 Mn by 2027-end. Being preferred route of drug administration by physicians, demand for oral controlled release drug delivery technology has been witnessing a surge by end-users in North America. In addition, recent advancements in drug delivery have enabled oral solid dosage manufacturers in North America to achieve significant bioavailability through adoption of novel drug delivery platforms. This is further expected to drive demand for oral controlled release drug delivery technology in the region.

Request to sample report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-4400

Western Europe will register the fastest expansion in the global oral controlled release drug delivery technology market. This growth is primarily attributed to a slew of new chemical entities resulting from high throughput screening, which have low solubility and bioavailability. This has further led manufacturers in this region to invest in drug delivery methods with better clinical outcome. Owing to cost-sensitiveness in Western European countries, technologies enhancing bioavailability will remain preferred drug delivery system. These factors are expected to drive growth of the market in this region.

Summary of Table of Content

1. Executive Summary
2. Market Introduction
3. Oral Controlled Release Drug Delivery Technology Market Opportunity Analysis
4. North America Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027
5. Latin America Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027
6. Western Europe Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027
7. Eastern Europe Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027
8. Asia Pacific excluding Japan Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027
9. Japan Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027
10. Middle East & Africa Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027
11. Forecast Factors: Relevance and Impact
12. Competition Landscape
13. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027, By Region
14. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027, By Drug Release Systems Type
15. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027, By Dosage Form
16. Global Oral Controlled Release Drug Delivery Technology Market Analysis 2012–2016 and Forecast 2017–2027
17. Assumptions and Acronyms Used

Request to Browse Full Table of Content, figure and Tables@ https://www.futuremarketinsights.com/toc/rep-gb-4400

ABOUT US:

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:

Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: [email protected]
Website: www.futuremarketinsights.com
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Future Market Insights
Country United States
Categories Health , Medical , News
Tags oral controlled release drug delivery technology market
Last Updated December 15, 2017